News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tamir Biotechnology, Inc. (Formerly Known as Alfacell Corporation) (ACEL)'s Compounds Show Remarkable Results Against Dengue Virus



7/19/2010 10:02:22 AM

SOMERSET, N.J., July 19, 2010 (GLOBE NEWSWIRE) -- Tamir Biotechnology, Inc. (formerly Alfacell Corporation) (OTCBB:ACEL) announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) confirmed that testing of three (3) of the company's compounds Onconase® (Ranpirnase), Natural P31, and Recombinant Amphinase 2 showed in vitro results rarely seen before by the U.S. government for the Dengue virus.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES